Riyadh, Saudi Arabia – : Thakaa Med, a pioneering AI-driven healthcare innovator and a proud member of the Falak Angels Alumni, has successfully secured its first seed round investment through a syndicate led by Falak Angels. This strategic capital infusion will be instrumental in accelerating the enhancement of Thakaa Med’s advanced AI models and supporting the market launch of its flagship products, Dental IQ and Chest IQ.
The investment aligns seamlessly with Falak Angels’ mission to empower startups at the cutting edge of technological innovation. The syndicate’s backing reflects its commitment to fostering the next generation of tech-driven companies by providing both financial and strategic resources essential for their growth and impact.
“Falak Angels remains steadfast in our commitment to support tech startups that are redefining industries through innovation. Our role is not just as investors but as partners in their journey towards making a significant impact,” said Adwa Aldakheel, CEO of Falak Investment Hub.
Thakaa Med plans to leverage this investment to further advance its AI technologies, aiming to bring groundbreaking solutions to the healthcare sector. The company’s focus on predictive, preventive, and personalized healthcare technologies is poised to contribute significantly to the Kingdom’s Vision 2030, which emphasizes the importance of innovation in driving national development.
Specializing in AI-driven healthcare solutions, Thakaa Med is dedicated to transforming patient care through state-of-the-art technologies that anticipate healthcare needs and offer personalized treatment options.
Falak Angels is recognized as a leading investment enabler in the MENA region, linking visionary founders with smart capital. With a portfolio of over 180 startup alumni, Falak Angels provides the strategic support and capital necessary for innovative startups to thrive and scale across the region.
